nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP2D6—Temsirolimus—kidney cancer	0.101	0.169	CbGbCtD
Darifenacin—CYP3A4—Everolimus—kidney cancer	0.0949	0.159	CbGbCtD
Darifenacin—CYP3A4—Temsirolimus—kidney cancer	0.0641	0.108	CbGbCtD
Darifenacin—CYP2D6—Pazopanib—kidney cancer	0.053	0.0889	CbGbCtD
Darifenacin—CYP2D6—Erlotinib—kidney cancer	0.0378	0.0635	CbGbCtD
Darifenacin—CYP3A4—Pazopanib—kidney cancer	0.0337	0.0565	CbGbCtD
Darifenacin—CYP2D6—Sorafenib—kidney cancer	0.0307	0.0516	CbGbCtD
Darifenacin—CYP2D6—Vinblastine—kidney cancer	0.0303	0.0509	CbGbCtD
Darifenacin—CYP3A4—Erlotinib—kidney cancer	0.024	0.0404	CbGbCtD
Darifenacin—CYP3A4—Paclitaxel—kidney cancer	0.022	0.0369	CbGbCtD
Darifenacin—CYP3A4—Sorafenib—kidney cancer	0.0195	0.0328	CbGbCtD
Darifenacin—CYP3A4—Vinblastine—kidney cancer	0.0193	0.0324	CbGbCtD
Darifenacin—CYP3A4—Vincristine—kidney cancer	0.019	0.0319	CbGbCtD
Darifenacin—CYP2D6—Doxorubicin—kidney cancer	0.0186	0.0313	CbGbCtD
Darifenacin—CYP3A4—Sunitinib—kidney cancer	0.0158	0.0266	CbGbCtD
Darifenacin—CHRM3—ureter—kidney cancer	0.0144	0.595	CbGeAlD
Darifenacin—CYP3A4—Doxorubicin—kidney cancer	0.0119	0.0199	CbGbCtD
Darifenacin—CYP3A4—urine—kidney cancer	0.00258	0.106	CbGeAlD
Darifenacin—CYP2D6—urine—kidney cancer	0.00253	0.105	CbGeAlD
Darifenacin—Loperamide—POMC—kidney cancer	0.002	0.602	CrCbGaD
Darifenacin—CHRM3—renal system—kidney cancer	0.00115	0.0473	CbGeAlD
Darifenacin—CHRM3—kidney—kidney cancer	0.00111	0.0457	CbGeAlD
Darifenacin—CYP3A4—renal system—kidney cancer	0.00063	0.026	CbGeAlD
Darifenacin—CYP2D6—renal system—kidney cancer	0.00062	0.0256	CbGeAlD
Darifenacin—CYP3A4—kidney—kidney cancer	0.000609	0.0251	CbGeAlD
Darifenacin—CYP2D6—kidney—kidney cancer	0.0006	0.0247	CbGeAlD
Darifenacin—Hyperhidrosis—Vincristine—kidney cancer	0.0004	0.00108	CcSEcCtD
Darifenacin—Pruritus—Erlotinib—kidney cancer	0.0004	0.00108	CcSEcCtD
Darifenacin—Flatulence—Paclitaxel—kidney cancer	0.000397	0.00107	CcSEcCtD
Darifenacin—Pain—Dactinomycin—kidney cancer	0.000396	0.00107	CcSEcCtD
Darifenacin—Dysgeusia—Paclitaxel—kidney cancer	0.000394	0.00107	CcSEcCtD
Darifenacin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000392	0.00106	CcSEcCtD
Darifenacin—Oedema—Gemcitabine—kidney cancer	0.000392	0.00106	CcSEcCtD
Darifenacin—Infection—Gemcitabine—kidney cancer	0.00039	0.00106	CcSEcCtD
Darifenacin—Back pain—Paclitaxel—kidney cancer	0.000389	0.00106	CcSEcCtD
Darifenacin—Dizziness—Vinblastine—kidney cancer	0.000389	0.00105	CcSEcCtD
Darifenacin—Dizziness—Everolimus—kidney cancer	0.000387	0.00105	CcSEcCtD
Darifenacin—Abdominal pain—Sunitinib—kidney cancer	0.000386	0.00105	CcSEcCtD
Darifenacin—Diarrhoea—Erlotinib—kidney cancer	0.000386	0.00105	CcSEcCtD
Darifenacin—Nervous system disorder—Gemcitabine—kidney cancer	0.000385	0.00104	CcSEcCtD
Darifenacin—Feeling abnormal—Dactinomycin—kidney cancer	0.000381	0.00103	CcSEcCtD
Darifenacin—Skin disorder—Gemcitabine—kidney cancer	0.000381	0.00103	CcSEcCtD
Darifenacin—Rhinitis—Capecitabine—kidney cancer	0.00038	0.00103	CcSEcCtD
Darifenacin—Vision blurred—Paclitaxel—kidney cancer	0.000379	0.00103	CcSEcCtD
Darifenacin—Hyperhidrosis—Gemcitabine—kidney cancer	0.000379	0.00103	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000378	0.00103	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000377	0.00102	CcSEcCtD
Darifenacin—Pharyngitis—Capecitabine—kidney cancer	0.000377	0.00102	CcSEcCtD
Darifenacin—Urinary tract disorder—Capecitabine—kidney cancer	0.000375	0.00102	CcSEcCtD
Darifenacin—Hypersensitivity—Sorafenib—kidney cancer	0.000374	0.00101	CcSEcCtD
Darifenacin—Fexofenadine—ABCB1—kidney cancer	0.000374	0.113	CrCbGaD
Darifenacin—Insomnia—Vincristine—kidney cancer	0.000374	0.00101	CcSEcCtD
Darifenacin—Oedema peripheral—Capecitabine—kidney cancer	0.000374	0.00101	CcSEcCtD
Darifenacin—Vomiting—Vinblastine—kidney cancer	0.000374	0.00101	CcSEcCtD
Darifenacin—Dizziness—Erlotinib—kidney cancer	0.000373	0.00101	CcSEcCtD
Darifenacin—Vomiting—Everolimus—kidney cancer	0.000372	0.00101	CcSEcCtD
Darifenacin—Urethral disorder—Capecitabine—kidney cancer	0.000372	0.00101	CcSEcCtD
Darifenacin—Rash—Everolimus—kidney cancer	0.000369	0.001	CcSEcCtD
Darifenacin—Dermatitis—Everolimus—kidney cancer	0.000369	0.000999	CcSEcCtD
Darifenacin—Headache—Vinblastine—kidney cancer	0.000368	0.000998	CcSEcCtD
Darifenacin—Angioedema—Paclitaxel—kidney cancer	0.000368	0.000997	CcSEcCtD
Darifenacin—Headache—Everolimus—kidney cancer	0.000367	0.000994	CcSEcCtD
Darifenacin—Abdominal pain—Dactinomycin—kidney cancer	0.000366	0.000992	CcSEcCtD
Darifenacin—Visual impairment—Capecitabine—kidney cancer	0.000366	0.000991	CcSEcCtD
Darifenacin—Asthenia—Sorafenib—kidney cancer	0.000365	0.000988	CcSEcCtD
Darifenacin—Syncope—Paclitaxel—kidney cancer	0.000361	0.000978	CcSEcCtD
Darifenacin—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000361	0.000978	CcSEcCtD
Darifenacin—Hypersensitivity—Sunitinib—kidney cancer	0.00036	0.000976	CcSEcCtD
Darifenacin—Pruritus—Sorafenib—kidney cancer	0.000359	0.000974	CcSEcCtD
Darifenacin—Vomiting—Erlotinib—kidney cancer	0.000359	0.000973	CcSEcCtD
Darifenacin—Erythema multiforme—Capecitabine—kidney cancer	0.000359	0.000972	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000357	0.000969	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000357	0.000968	CcSEcCtD
Darifenacin—Rash—Erlotinib—kidney cancer	0.000356	0.000965	CcSEcCtD
Darifenacin—Dermatitis—Erlotinib—kidney cancer	0.000356	0.000964	CcSEcCtD
Darifenacin—Palpitations—Paclitaxel—kidney cancer	0.000356	0.000964	CcSEcCtD
Darifenacin—Insomnia—Gemcitabine—kidney cancer	0.000355	0.000962	CcSEcCtD
Darifenacin—Eye disorder—Capecitabine—kidney cancer	0.000355	0.000961	CcSEcCtD
Darifenacin—Headache—Erlotinib—kidney cancer	0.000354	0.000959	CcSEcCtD
Darifenacin—Loss of consciousness—Paclitaxel—kidney cancer	0.000354	0.000959	CcSEcCtD
Darifenacin—Pain—Vincristine—kidney cancer	0.000354	0.000959	CcSEcCtD
Darifenacin—Constipation—Vincristine—kidney cancer	0.000354	0.000959	CcSEcCtD
Darifenacin—Cough—Paclitaxel—kidney cancer	0.000351	0.000952	CcSEcCtD
Darifenacin—Asthenia—Sunitinib—kidney cancer	0.000351	0.000951	CcSEcCtD
Darifenacin—Dyspnoea—Gemcitabine—kidney cancer	0.00035	0.000948	CcSEcCtD
Darifenacin—Nausea—Vinblastine—kidney cancer	0.000349	0.000946	CcSEcCtD
Darifenacin—Somnolence—Gemcitabine—kidney cancer	0.000349	0.000945	CcSEcCtD
Darifenacin—Nausea—Everolimus—kidney cancer	0.000348	0.000942	CcSEcCtD
Darifenacin—Diarrhoea—Sorafenib—kidney cancer	0.000348	0.000942	CcSEcCtD
Darifenacin—Hypertension—Paclitaxel—kidney cancer	0.000347	0.000942	CcSEcCtD
Darifenacin—Pruritus—Sunitinib—kidney cancer	0.000346	0.000938	CcSEcCtD
Darifenacin—Angiopathy—Capecitabine—kidney cancer	0.000344	0.000933	CcSEcCtD
Darifenacin—Arthralgia—Paclitaxel—kidney cancer	0.000343	0.000929	CcSEcCtD
Darifenacin—Mediastinal disorder—Capecitabine—kidney cancer	0.000342	0.000927	CcSEcCtD
Darifenacin—Face oedema—Doxorubicin—kidney cancer	0.000341	0.000925	CcSEcCtD
Darifenacin—Hypersensitivity—Dactinomycin—kidney cancer	0.000341	0.000924	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00034	0.000922	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000339	0.000918	CcSEcCtD
Darifenacin—Gastrointestinal pain—Vincristine—kidney cancer	0.000338	0.000917	CcSEcCtD
Darifenacin—Dizziness—Sorafenib—kidney cancer	0.000336	0.000911	CcSEcCtD
Darifenacin—Constipation—Gemcitabine—kidney cancer	0.000335	0.000909	CcSEcCtD
Darifenacin—Pain—Gemcitabine—kidney cancer	0.000335	0.000909	CcSEcCtD
Darifenacin—Nausea—Erlotinib—kidney cancer	0.000335	0.000909	CcSEcCtD
Darifenacin—Dry mouth—Paclitaxel—kidney cancer	0.000335	0.000908	CcSEcCtD
Darifenacin—Diarrhoea—Sunitinib—kidney cancer	0.000334	0.000907	CcSEcCtD
Darifenacin—Mental disorder—Capecitabine—kidney cancer	0.000332	0.000901	CcSEcCtD
Darifenacin—Asthenia—Dactinomycin—kidney cancer	0.000332	0.0009	CcSEcCtD
Darifenacin—Confusional state—Paclitaxel—kidney cancer	0.000331	0.000898	CcSEcCtD
Darifenacin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000328	0.00089	CcSEcCtD
Darifenacin—Oedema—Paclitaxel—kidney cancer	0.000328	0.00089	CcSEcCtD
Darifenacin—Abdominal pain—Vincristine—kidney cancer	0.000327	0.000886	CcSEcCtD
Darifenacin—Infection—Paclitaxel—kidney cancer	0.000326	0.000884	CcSEcCtD
Darifenacin—Flatulence—Capecitabine—kidney cancer	0.000325	0.000882	CcSEcCtD
Darifenacin—Dry skin—Doxorubicin—kidney cancer	0.000324	0.000878	CcSEcCtD
Darifenacin—Dysgeusia—Capecitabine—kidney cancer	0.000323	0.000877	CcSEcCtD
Darifenacin—Dizziness—Sunitinib—kidney cancer	0.000323	0.000876	CcSEcCtD
Darifenacin—Feeling abnormal—Gemcitabine—kidney cancer	0.000323	0.000876	CcSEcCtD
Darifenacin—Shock—Paclitaxel—kidney cancer	0.000323	0.000876	CcSEcCtD
Darifenacin—Vomiting—Sorafenib—kidney cancer	0.000323	0.000876	CcSEcCtD
Darifenacin—Nervous system disorder—Paclitaxel—kidney cancer	0.000322	0.000873	CcSEcCtD
Darifenacin—Tachycardia—Paclitaxel—kidney cancer	0.000321	0.000869	CcSEcCtD
Darifenacin—Rash—Sorafenib—kidney cancer	0.00032	0.000868	CcSEcCtD
Darifenacin—Dermatitis—Sorafenib—kidney cancer	0.00032	0.000868	CcSEcCtD
Darifenacin—Back pain—Capecitabine—kidney cancer	0.000319	0.000866	CcSEcCtD
Darifenacin—Breast disorder—Doxorubicin—kidney cancer	0.000319	0.000866	CcSEcCtD
Darifenacin—Skin disorder—Paclitaxel—kidney cancer	0.000319	0.000865	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000318	0.000863	CcSEcCtD
Darifenacin—Headache—Sorafenib—kidney cancer	0.000318	0.000863	CcSEcCtD
Darifenacin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000318	0.000861	CcSEcCtD
Darifenacin—Diarrhoea—Dactinomycin—kidney cancer	0.000317	0.000858	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000312	0.000845	CcSEcCtD
Darifenacin—Vision blurred—Capecitabine—kidney cancer	0.000311	0.000844	CcSEcCtD
Darifenacin—Vomiting—Sunitinib—kidney cancer	0.000311	0.000843	CcSEcCtD
Darifenacin—Rash—Sunitinib—kidney cancer	0.000308	0.000836	CcSEcCtD
Darifenacin—Dermatitis—Sunitinib—kidney cancer	0.000308	0.000835	CcSEcCtD
Darifenacin—Headache—Sunitinib—kidney cancer	0.000306	0.00083	CcSEcCtD
Darifenacin—Influenza—Doxorubicin—kidney cancer	0.000306	0.000828	CcSEcCtD
Darifenacin—Hypersensitivity—Vincristine—kidney cancer	0.000305	0.000826	CcSEcCtD
Darifenacin—Nausea—Sorafenib—kidney cancer	0.000302	0.000818	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000299	0.000811	CcSEcCtD
Darifenacin—Insomnia—Paclitaxel—kidney cancer	0.000297	0.000805	CcSEcCtD
Darifenacin—Asthenia—Vincristine—kidney cancer	0.000297	0.000804	CcSEcCtD
Darifenacin—Syncope—Capecitabine—kidney cancer	0.000296	0.000803	CcSEcCtD
Darifenacin—Vomiting—Dactinomycin—kidney cancer	0.000294	0.000798	CcSEcCtD
Darifenacin—Bronchitis—Doxorubicin—kidney cancer	0.000294	0.000796	CcSEcCtD
Darifenacin—Dyspnoea—Paclitaxel—kidney cancer	0.000293	0.000794	CcSEcCtD
Darifenacin—Somnolence—Paclitaxel—kidney cancer	0.000292	0.000791	CcSEcCtD
Darifenacin—Palpitations—Capecitabine—kidney cancer	0.000292	0.000791	CcSEcCtD
Darifenacin—Rash—Dactinomycin—kidney cancer	0.000292	0.000791	CcSEcCtD
Darifenacin—Nausea—Sunitinib—kidney cancer	0.00029	0.000787	CcSEcCtD
Darifenacin—Loss of consciousness—Capecitabine—kidney cancer	0.00029	0.000787	CcSEcCtD
Darifenacin—Dyspepsia—Paclitaxel—kidney cancer	0.000289	0.000784	CcSEcCtD
Darifenacin—Clotrimazole—ABCB1—kidney cancer	0.000289	0.0872	CrCbGaD
Darifenacin—Cough—Capecitabine—kidney cancer	0.000288	0.000781	CcSEcCtD
Darifenacin—Hypertension—Capecitabine—kidney cancer	0.000285	0.000773	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000284	0.000769	CcSEcCtD
Darifenacin—Diarrhoea—Vincristine—kidney cancer	0.000283	0.000767	CcSEcCtD
Darifenacin—Asthenia—Gemcitabine—kidney cancer	0.000281	0.000763	CcSEcCtD
Darifenacin—Arthralgia—Capecitabine—kidney cancer	0.000281	0.000762	CcSEcCtD
Darifenacin—Pain—Paclitaxel—kidney cancer	0.000281	0.000761	CcSEcCtD
Darifenacin—Constipation—Paclitaxel—kidney cancer	0.000281	0.000761	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000279	0.000757	CcSEcCtD
Darifenacin—Weight increased—Doxorubicin—kidney cancer	0.000278	0.000754	CcSEcCtD
Darifenacin—Pruritus—Gemcitabine—kidney cancer	0.000278	0.000752	CcSEcCtD
Darifenacin—Dry mouth—Capecitabine—kidney cancer	0.000275	0.000745	CcSEcCtD
Darifenacin—Nausea—Dactinomycin—kidney cancer	0.000275	0.000745	CcSEcCtD
Darifenacin—Dizziness—Vincristine—kidney cancer	0.000273	0.000741	CcSEcCtD
Darifenacin—Infestation—Doxorubicin—kidney cancer	0.000272	0.000738	CcSEcCtD
Darifenacin—Infestation NOS—Doxorubicin—kidney cancer	0.000272	0.000738	CcSEcCtD
Darifenacin—Confusional state—Capecitabine—kidney cancer	0.000272	0.000737	CcSEcCtD
Darifenacin—Feeling abnormal—Paclitaxel—kidney cancer	0.000271	0.000734	CcSEcCtD
Darifenacin—Oedema—Capecitabine—kidney cancer	0.00027	0.000731	CcSEcCtD
Darifenacin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000269	0.000728	CcSEcCtD
Darifenacin—Diarrhoea—Gemcitabine—kidney cancer	0.000268	0.000728	CcSEcCtD
Darifenacin—Infection—Capecitabine—kidney cancer	0.000268	0.000726	CcSEcCtD
Darifenacin—Stomatitis—Doxorubicin—kidney cancer	0.000266	0.00072	CcSEcCtD
Darifenacin—Shock—Capecitabine—kidney cancer	0.000265	0.000719	CcSEcCtD
Darifenacin—Urinary tract infection—Doxorubicin—kidney cancer	0.000265	0.000718	CcSEcCtD
Darifenacin—Nervous system disorder—Capecitabine—kidney cancer	0.000264	0.000717	CcSEcCtD
Darifenacin—Tachycardia—Capecitabine—kidney cancer	0.000263	0.000713	CcSEcCtD
Darifenacin—Vomiting—Vincristine—kidney cancer	0.000263	0.000713	CcSEcCtD
Darifenacin—Skin disorder—Capecitabine—kidney cancer	0.000262	0.00071	CcSEcCtD
Darifenacin—Sweating—Doxorubicin—kidney cancer	0.000261	0.000708	CcSEcCtD
Darifenacin—Rash—Vincristine—kidney cancer	0.000261	0.000707	CcSEcCtD
Darifenacin—Hyperhidrosis—Capecitabine—kidney cancer	0.000261	0.000706	CcSEcCtD
Darifenacin—Dermatitis—Vincristine—kidney cancer	0.00026	0.000706	CcSEcCtD
Darifenacin—Abdominal pain—Paclitaxel—kidney cancer	0.00026	0.000704	CcSEcCtD
Darifenacin—Headache—Vincristine—kidney cancer	0.000259	0.000702	CcSEcCtD
Darifenacin—Sinusitis—Doxorubicin—kidney cancer	0.000256	0.000693	CcSEcCtD
Darifenacin—Vomiting—Gemcitabine—kidney cancer	0.000249	0.000676	CcSEcCtD
Darifenacin—Rash—Gemcitabine—kidney cancer	0.000247	0.00067	CcSEcCtD
Darifenacin—Fentanyl—ABCB1—kidney cancer	0.000247	0.0745	CrCbGaD
Darifenacin—Dermatitis—Gemcitabine—kidney cancer	0.000247	0.00067	CcSEcCtD
Darifenacin—Headache—Gemcitabine—kidney cancer	0.000246	0.000666	CcSEcCtD
Darifenacin—Nausea—Vincristine—kidney cancer	0.000246	0.000666	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000246	0.000666	CcSEcCtD
Darifenacin—Rhinitis—Doxorubicin—kidney cancer	0.000245	0.000665	CcSEcCtD
Darifenacin—Insomnia—Capecitabine—kidney cancer	0.000244	0.000661	CcSEcCtD
Darifenacin—Pharyngitis—Doxorubicin—kidney cancer	0.000243	0.000658	CcSEcCtD
Darifenacin—Hypersensitivity—Paclitaxel—kidney cancer	0.000242	0.000656	CcSEcCtD
Darifenacin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000241	0.000655	CcSEcCtD
Darifenacin—Oedema peripheral—Doxorubicin—kidney cancer	0.000241	0.000653	CcSEcCtD
Darifenacin—Dyspnoea—Capecitabine—kidney cancer	0.00024	0.000651	CcSEcCtD
Darifenacin—Urethral disorder—Doxorubicin—kidney cancer	0.00024	0.00065	CcSEcCtD
Darifenacin—Loperamide—ABCB1—kidney cancer	0.000238	0.0718	CrCbGaD
Darifenacin—Dyspepsia—Capecitabine—kidney cancer	0.000237	0.000643	CcSEcCtD
Darifenacin—Visual impairment—Doxorubicin—kidney cancer	0.000236	0.000639	CcSEcCtD
Darifenacin—Asthenia—Paclitaxel—kidney cancer	0.000236	0.000639	CcSEcCtD
Darifenacin—Nausea—Gemcitabine—kidney cancer	0.000233	0.000632	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000233	0.000631	CcSEcCtD
Darifenacin—Pruritus—Paclitaxel—kidney cancer	0.000232	0.00063	CcSEcCtD
Darifenacin—Erythema multiforme—Doxorubicin—kidney cancer	0.000231	0.000627	CcSEcCtD
Darifenacin—Constipation—Capecitabine—kidney cancer	0.00023	0.000625	CcSEcCtD
Darifenacin—Pain—Capecitabine—kidney cancer	0.00023	0.000625	CcSEcCtD
Darifenacin—Eye disorder—Doxorubicin—kidney cancer	0.000229	0.00062	CcSEcCtD
Darifenacin—Diarrhoea—Paclitaxel—kidney cancer	0.000225	0.000609	CcSEcCtD
Darifenacin—Feeling abnormal—Capecitabine—kidney cancer	0.000222	0.000602	CcSEcCtD
Darifenacin—Angiopathy—Doxorubicin—kidney cancer	0.000222	0.000601	CcSEcCtD
Darifenacin—Gastrointestinal pain—Capecitabine—kidney cancer	0.00022	0.000597	CcSEcCtD
Darifenacin—Mediastinal disorder—Doxorubicin—kidney cancer	0.00022	0.000597	CcSEcCtD
Darifenacin—Dizziness—Paclitaxel—kidney cancer	0.000217	0.000589	CcSEcCtD
Darifenacin—Mental disorder—Doxorubicin—kidney cancer	0.000214	0.000581	CcSEcCtD
Darifenacin—Abdominal pain—Capecitabine—kidney cancer	0.000213	0.000578	CcSEcCtD
Darifenacin—Flatulence—Doxorubicin—kidney cancer	0.00021	0.000569	CcSEcCtD
Darifenacin—Vomiting—Paclitaxel—kidney cancer	0.000209	0.000566	CcSEcCtD
Darifenacin—Dysgeusia—Doxorubicin—kidney cancer	0.000208	0.000565	CcSEcCtD
Darifenacin—Rash—Paclitaxel—kidney cancer	0.000207	0.000561	CcSEcCtD
Darifenacin—Dermatitis—Paclitaxel—kidney cancer	0.000207	0.000561	CcSEcCtD
Darifenacin—Back pain—Doxorubicin—kidney cancer	0.000206	0.000558	CcSEcCtD
Darifenacin—Headache—Paclitaxel—kidney cancer	0.000206	0.000558	CcSEcCtD
Darifenacin—Vision blurred—Doxorubicin—kidney cancer	0.000201	0.000544	CcSEcCtD
Darifenacin—Hypersensitivity—Capecitabine—kidney cancer	0.000199	0.000538	CcSEcCtD
Darifenacin—Nausea—Paclitaxel—kidney cancer	0.000195	0.000529	CcSEcCtD
Darifenacin—Asthenia—Capecitabine—kidney cancer	0.000193	0.000524	CcSEcCtD
Darifenacin—Syncope—Doxorubicin—kidney cancer	0.000191	0.000517	CcSEcCtD
Darifenacin—Pruritus—Capecitabine—kidney cancer	0.000191	0.000517	CcSEcCtD
Darifenacin—Palpitations—Doxorubicin—kidney cancer	0.000188	0.00051	CcSEcCtD
Darifenacin—Loss of consciousness—Doxorubicin—kidney cancer	0.000187	0.000507	CcSEcCtD
Darifenacin—Cough—Doxorubicin—kidney cancer	0.000186	0.000504	CcSEcCtD
Darifenacin—Diarrhoea—Capecitabine—kidney cancer	0.000184	0.0005	CcSEcCtD
Darifenacin—Hypertension—Doxorubicin—kidney cancer	0.000184	0.000498	CcSEcCtD
Darifenacin—Arthralgia—Doxorubicin—kidney cancer	0.000181	0.000491	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00018	0.000488	CcSEcCtD
Darifenacin—Dizziness—Capecitabine—kidney cancer	0.000178	0.000483	CcSEcCtD
Darifenacin—Dry mouth—Doxorubicin—kidney cancer	0.000177	0.00048	CcSEcCtD
Darifenacin—Confusional state—Doxorubicin—kidney cancer	0.000175	0.000475	CcSEcCtD
Darifenacin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000174	0.000471	CcSEcCtD
Darifenacin—Oedema—Doxorubicin—kidney cancer	0.000174	0.000471	CcSEcCtD
Darifenacin—Infection—Doxorubicin—kidney cancer	0.000173	0.000468	CcSEcCtD
Darifenacin—Vomiting—Capecitabine—kidney cancer	0.000171	0.000465	CcSEcCtD
Darifenacin—Shock—Doxorubicin—kidney cancer	0.000171	0.000463	CcSEcCtD
Darifenacin—Nervous system disorder—Doxorubicin—kidney cancer	0.00017	0.000462	CcSEcCtD
Darifenacin—Rash—Capecitabine—kidney cancer	0.00017	0.000461	CcSEcCtD
Darifenacin—Dermatitis—Capecitabine—kidney cancer	0.00017	0.00046	CcSEcCtD
Darifenacin—Tachycardia—Doxorubicin—kidney cancer	0.00017	0.00046	CcSEcCtD
Darifenacin—Methadone—ABCB1—kidney cancer	0.000169	0.0511	CrCbGaD
Darifenacin—Headache—Capecitabine—kidney cancer	0.000169	0.000458	CcSEcCtD
Darifenacin—Skin disorder—Doxorubicin—kidney cancer	0.000169	0.000457	CcSEcCtD
Darifenacin—Hyperhidrosis—Doxorubicin—kidney cancer	0.000168	0.000455	CcSEcCtD
Darifenacin—Nausea—Capecitabine—kidney cancer	0.00016	0.000434	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000158	0.000429	CcSEcCtD
Darifenacin—Insomnia—Doxorubicin—kidney cancer	0.000157	0.000426	CcSEcCtD
Darifenacin—Dyspnoea—Doxorubicin—kidney cancer	0.000155	0.00042	CcSEcCtD
Darifenacin—Somnolence—Doxorubicin—kidney cancer	0.000154	0.000419	CcSEcCtD
Darifenacin—Dyspepsia—Doxorubicin—kidney cancer	0.000153	0.000415	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00015	0.000407	CcSEcCtD
Darifenacin—Pain—Doxorubicin—kidney cancer	0.000149	0.000403	CcSEcCtD
Darifenacin—Constipation—Doxorubicin—kidney cancer	0.000149	0.000403	CcSEcCtD
Darifenacin—Feeling abnormal—Doxorubicin—kidney cancer	0.000143	0.000388	CcSEcCtD
Darifenacin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000142	0.000385	CcSEcCtD
Darifenacin—Abdominal pain—Doxorubicin—kidney cancer	0.000137	0.000372	CcSEcCtD
Darifenacin—Hypersensitivity—Doxorubicin—kidney cancer	0.000128	0.000347	CcSEcCtD
Darifenacin—Asthenia—Doxorubicin—kidney cancer	0.000125	0.000338	CcSEcCtD
Darifenacin—Pruritus—Doxorubicin—kidney cancer	0.000123	0.000333	CcSEcCtD
Darifenacin—Diarrhoea—Doxorubicin—kidney cancer	0.000119	0.000322	CcSEcCtD
Darifenacin—Dizziness—Doxorubicin—kidney cancer	0.000115	0.000311	CcSEcCtD
Darifenacin—Vomiting—Doxorubicin—kidney cancer	0.00011	0.000299	CcSEcCtD
Darifenacin—Rash—Doxorubicin—kidney cancer	0.00011	0.000297	CcSEcCtD
Darifenacin—Dermatitis—Doxorubicin—kidney cancer	0.000109	0.000297	CcSEcCtD
Darifenacin—Headache—Doxorubicin—kidney cancer	0.000109	0.000295	CcSEcCtD
Darifenacin—Nausea—Doxorubicin—kidney cancer	0.000103	0.00028	CcSEcCtD
Darifenacin—CHRM5—Signaling Pathways—CDKN2B—kidney cancer	4.33e-06	0.000537	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APRT—kidney cancer	4.23e-06	0.000525	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—FH—kidney cancer	4.23e-06	0.000525	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—RAF1—kidney cancer	4.23e-06	0.000524	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1R—kidney cancer	4.2e-06	0.000521	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—kidney cancer	4.17e-06	0.000518	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSC1—kidney cancer	4.17e-06	0.000517	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ANXA1—kidney cancer	4.17e-06	0.000517	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PSMD7—kidney cancer	4.17e-06	0.000517	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSC1—kidney cancer	4.16e-06	0.000515	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PSMD7—kidney cancer	4.16e-06	0.000515	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ANXA1—kidney cancer	4.16e-06	0.000515	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ANXA1—kidney cancer	4.12e-06	0.00051	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PSMD7—kidney cancer	4.12e-06	0.00051	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSC1—kidney cancer	4.12e-06	0.00051	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—RAF1—kidney cancer	4.05e-06	0.000502	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FLT1—kidney cancer	4.04e-06	0.000501	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FLT1—kidney cancer	4.03e-06	0.000499	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—kidney cancer	4e-06	0.000496	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FLT1—kidney cancer	3.99e-06	0.000494	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPC3—kidney cancer	3.98e-06	0.000493	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA2—kidney cancer	3.87e-06	0.00048	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CRABP1—kidney cancer	3.81e-06	0.000473	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—kidney cancer	3.81e-06	0.000472	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—kidney cancer	3.8e-06	0.000471	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—kidney cancer	3.79e-06	0.00047	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALAD—kidney cancer	3.77e-06	0.000468	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—kidney cancer	3.76e-06	0.000466	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTP1—kidney cancer	3.75e-06	0.000465	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JUNB—kidney cancer	3.74e-06	0.000464	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PAK1—kidney cancer	3.74e-06	0.000464	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JUNB—kidney cancer	3.73e-06	0.000463	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PAK1—kidney cancer	3.73e-06	0.000463	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JUNB—kidney cancer	3.7e-06	0.000458	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PAK1—kidney cancer	3.7e-06	0.000458	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.68e-06	0.000457	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—kidney cancer	3.63e-06	0.00045	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HIF1A—kidney cancer	3.61e-06	0.000448	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TSC2—kidney cancer	3.6e-06	0.000447	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.6e-06	0.000446	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ABCB1—kidney cancer	3.55e-06	0.00044	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ITPR2—kidney cancer	3.55e-06	0.00044	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HIF1A—kidney cancer	3.46e-06	0.000429	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—kidney cancer	3.46e-06	0.000429	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KDR—kidney cancer	3.45e-06	0.000428	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TSC2—kidney cancer	3.45e-06	0.000428	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PGK1—kidney cancer	3.45e-06	0.000428	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.45e-06	0.000428	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—kidney cancer	3.45e-06	0.000428	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GSTM1—kidney cancer	3.45e-06	0.000427	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—kidney cancer	3.41e-06	0.000423	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LDHB—kidney cancer	3.38e-06	0.00042	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KDR—kidney cancer	3.31e-06	0.00041	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP1A1—kidney cancer	3.27e-06	0.000405	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ACHE—kidney cancer	3.23e-06	0.000401	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTT1—kidney cancer	3.23e-06	0.000401	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APC—kidney cancer	3.18e-06	0.000395	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KIT—kidney cancer	3.18e-06	0.000395	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SCARB1—kidney cancer	3.06e-06	0.00038	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF2—kidney cancer	3.06e-06	0.00038	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF2—kidney cancer	3.05e-06	0.000378	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK3—kidney cancer	3.05e-06	0.000378	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APC—kidney cancer	3.05e-06	0.000378	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KIT—kidney cancer	3.05e-06	0.000378	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	3.05e-06	0.000378	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN2B—kidney cancer	3.04e-06	0.000377	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS1—kidney cancer	3.03e-06	0.000376	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—kidney cancer	3.03e-06	0.000376	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF2—kidney cancer	3.02e-06	0.000375	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	3.01e-06	0.000373	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—BRAF—kidney cancer	2.99e-06	0.000371	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PSMD7—kidney cancer	2.97e-06	0.000369	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1R—kidney cancer	2.96e-06	0.000367	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1R—kidney cancer	2.95e-06	0.000366	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA9—kidney cancer	2.93e-06	0.000364	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1R—kidney cancer	2.92e-06	0.000362	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK3—kidney cancer	2.92e-06	0.000362	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—kidney cancer	2.9e-06	0.00036	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—MAPK1—kidney cancer	2.9e-06	0.00036	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BRAF—kidney cancer	2.86e-06	0.000355	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—RAF1—kidney cancer	2.85e-06	0.000354	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—RAF1—kidney cancer	2.84e-06	0.000352	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BCHE—kidney cancer	2.82e-06	0.000349	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—kidney cancer	2.82e-06	0.000349	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—RAF1—kidney cancer	2.81e-06	0.000349	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—kidney cancer	2.81e-06	0.000348	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SLC5A5—kidney cancer	2.78e-06	0.000345	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—kidney cancer	2.78e-06	0.000345	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—MAPK1—kidney cancer	2.78e-06	0.000344	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PIK3CA—kidney cancer	2.77e-06	0.000344	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—KRAS—kidney cancer	2.74e-06	0.00034	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—SLC2A1—kidney cancer	2.69e-06	0.000333	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PIK3CA—kidney cancer	2.65e-06	0.000329	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—KRAS—kidney cancer	2.62e-06	0.000325	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—kidney cancer	2.56e-06	0.000317	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—kidney cancer	2.55e-06	0.000316	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—kidney cancer	2.52e-06	0.000313	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CA—kidney cancer	2.52e-06	0.000312	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RAF1—kidney cancer	2.5e-06	0.00031	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CRABP1—kidney cancer	2.49e-06	0.000309	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RELA—kidney cancer	2.49e-06	0.000308	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ERBB2—kidney cancer	2.47e-06	0.000306	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MTOR—kidney cancer	2.44e-06	0.000302	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HIF1A—kidney cancer	2.44e-06	0.000302	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—kidney cancer	2.44e-06	0.000302	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TSC2—kidney cancer	2.43e-06	0.000301	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HIF1A—kidney cancer	2.43e-06	0.000301	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TSC2—kidney cancer	2.42e-06	0.0003	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CA—kidney cancer	2.41e-06	0.000299	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HIF1A—kidney cancer	2.4e-06	0.000298	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TSC2—kidney cancer	2.4e-06	0.000297	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RAF1—kidney cancer	2.39e-06	0.000297	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RELA—kidney cancer	2.38e-06	0.000295	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ERBB2—kidney cancer	2.37e-06	0.000294	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MTOR—kidney cancer	2.34e-06	0.00029	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KDR—kidney cancer	2.33e-06	0.000289	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KDR—kidney cancer	2.32e-06	0.000288	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ITPR2—kidney cancer	2.32e-06	0.000288	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KDR—kidney cancer	2.3e-06	0.000285	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CDKN1B—kidney cancer	2.29e-06	0.000284	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTP1—kidney cancer	2.24e-06	0.000278	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—kidney cancer	2.24e-06	0.000278	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CDKN1B—kidney cancer	2.19e-06	0.000272	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCND1—kidney cancer	2.18e-06	0.000271	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JUN—kidney cancer	2.18e-06	0.00027	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CTNNB1—kidney cancer	2.16e-06	0.000268	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—kidney cancer	2.15e-06	0.000266	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KIT—kidney cancer	2.15e-06	0.000266	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—kidney cancer	2.14e-06	0.000266	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—kidney cancer	2.14e-06	0.000265	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KIT—kidney cancer	2.14e-06	0.000265	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCB1—kidney cancer	2.12e-06	0.000263	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KIT—kidney cancer	2.12e-06	0.000263	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—kidney cancer	2.12e-06	0.000263	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—kidney cancer	2.11e-06	0.000262	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ACHE—kidney cancer	2.11e-06	0.000262	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTEN—kidney cancer	2.11e-06	0.000261	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCND1—kidney cancer	2.09e-06	0.000259	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JUN—kidney cancer	2.09e-06	0.000259	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CTNNB1—kidney cancer	2.07e-06	0.000257	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTM1—kidney cancer	2.06e-06	0.000255	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	2.06e-06	0.000255	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK3—kidney cancer	2.05e-06	0.000254	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—kidney cancer	2.04e-06	0.000253	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—kidney cancer	2.04e-06	0.000253	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	2.03e-06	0.000252	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTEN—kidney cancer	2.02e-06	0.00025	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BRAF—kidney cancer	2.02e-06	0.00025	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—kidney cancer	2.02e-06	0.00025	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BRAF—kidney cancer	2.01e-06	0.000249	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SCARB1—kidney cancer	2e-06	0.000248	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BRAF—kidney cancer	1.99e-06	0.000247	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS1—kidney cancer	1.98e-06	0.000246	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	1.96e-06	0.000243	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP1A1—kidney cancer	1.95e-06	0.000242	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK1—kidney cancer	1.95e-06	0.000242	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PSMD7—kidney cancer	1.94e-06	0.000241	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—kidney cancer	1.94e-06	0.000241	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	1.93e-06	0.000239	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—kidney cancer	1.9e-06	0.000236	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	1.87e-06	0.000232	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CA—kidney cancer	1.86e-06	0.000231	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—KRAS—kidney cancer	1.85e-06	0.000229	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	1.84e-06	0.000229	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BCHE—kidney cancer	1.84e-06	0.000228	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—KRAS—kidney cancer	1.84e-06	0.000228	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—KRAS—kidney cancer	1.82e-06	0.000226	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—kidney cancer	1.82e-06	0.000226	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.82e-06	0.000226	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK3—kidney cancer	1.8e-06	0.000223	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.76e-06	0.000218	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—kidney cancer	1.75e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK3—kidney cancer	1.72e-06	0.000214	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK1—kidney cancer	1.71e-06	0.000212	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	1.7e-06	0.00021	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTEN—kidney cancer	1.69e-06	0.00021	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	1.69e-06	0.00021	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RAF1—kidney cancer	1.68e-06	0.000209	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RAF1—kidney cancer	1.68e-06	0.000208	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—kidney cancer	1.68e-06	0.000208	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RELA—kidney cancer	1.68e-06	0.000208	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	1.68e-06	0.000208	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RELA—kidney cancer	1.67e-06	0.000207	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ERBB2—kidney cancer	1.67e-06	0.000207	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RAF1—kidney cancer	1.66e-06	0.000206	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ERBB2—kidney cancer	1.66e-06	0.000206	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RELA—kidney cancer	1.66e-06	0.000205	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ERBB2—kidney cancer	1.64e-06	0.000204	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MTOR—kidney cancer	1.64e-06	0.000204	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK1—kidney cancer	1.64e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MTOR—kidney cancer	1.64e-06	0.000203	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MTOR—kidney cancer	1.62e-06	0.000201	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KRAS—kidney cancer	1.62e-06	0.000201	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KRAS—kidney cancer	1.55e-06	0.000192	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	1.54e-06	0.000191	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	1.54e-06	0.000191	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	1.52e-06	0.000189	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—kidney cancer	1.51e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—kidney cancer	1.51e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—kidney cancer	1.49e-06	0.000185	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	1.49e-06	0.000184	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCND1—kidney cancer	1.47e-06	0.000183	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JUN—kidney cancer	1.47e-06	0.000182	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCND1—kidney cancer	1.47e-06	0.000182	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTP1—kidney cancer	1.47e-06	0.000182	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JUN—kidney cancer	1.46e-06	0.000182	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	1.46e-06	0.000181	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—kidney cancer	1.46e-06	0.000181	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCND1—kidney cancer	1.45e-06	0.00018	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	1.45e-06	0.00018	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JUN—kidney cancer	1.45e-06	0.00018	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.44e-06	0.000178	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—kidney cancer	1.44e-06	0.000178	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	1.42e-06	0.000177	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTEN—kidney cancer	1.42e-06	0.000176	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTEN—kidney cancer	1.42e-06	0.000176	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.4e-06	0.000174	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCB1—kidney cancer	1.39e-06	0.000172	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—kidney cancer	1.38e-06	0.000171	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM1—kidney cancer	1.35e-06	0.000167	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—kidney cancer	1.28e-06	0.000159	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—kidney cancer	1.28e-06	0.000159	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.28e-06	0.000158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.27e-06	0.000157	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK3—kidney cancer	1.21e-06	0.000151	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK3—kidney cancer	1.21e-06	0.00015	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.2e-06	0.000149	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CA—kidney cancer	1.19e-06	0.000148	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—kidney cancer	1.18e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—kidney cancer	1.18e-06	0.000146	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—kidney cancer	1.17e-06	0.000145	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—kidney cancer	1.16e-06	0.000144	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.16e-06	0.000143	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.15e-06	0.000143	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.14e-06	0.000141	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.09e-06	0.000135	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.09e-06	0.000135	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.08e-06	0.000134	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTEN—kidney cancer	1.01e-06	0.000126	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1e-06	0.000124	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	9.99e-07	0.000124	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	9.9e-07	0.000123	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—kidney cancer	9.7e-07	0.00012	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—kidney cancer	9.67e-07	0.00012	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—kidney cancer	9.57e-07	0.000119	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—kidney cancer	9.52e-07	0.000118	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—kidney cancer	7.59e-07	9.42e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CA—kidney cancer	7.15e-07	8.86e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTEN—kidney cancer	6.62e-07	8.21e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.67e-07	5.79e-05	CbGpPWpGaD
